[Federal Register: May 10, 2006 (Volume 71, Number 90)]
[Notices]
[Page 27239-27240]
[DOCID:fr10my06-47]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OAR-2005-0509, FRL 8168-2]

Agency Information Collection Activities: Submission to OMB for
Review and Approval; Comment Request; Acid Rain Program Under Title IV
of the CAA Amendments of 1990 (Renewal), EPA ICR Number 1633.14, OMB
Control Number 2060-0258

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), this document announces that an Information
Collection Request (ICF) has been forwarded to the Office of Management
and Budget (OMB) for review and approval. This is a request to renew an
existing approved collection. The ICR, which is abstracted below,
describes the nature of the information collection and its estimated
burden and cost.

DATES: Additional comments must be submitted on or before June 9, 2006.

ADDRESSES: Submit your comments, referencing Docket ID No. EPA-HQ-OAR-
2005-0509, to (1) EPA online using http://www.regulations.gov (our preferred method), by e-mail to<EMAIL_ADDRESS>or by mail to: EPA Docket

Center (EPA/DC), Environmental Protection Agency, Air and Radiation
Docket and Information Center, Environmental Protection Agency,
Mailcode: 6102T, 1200 Pennsylvania Avenue, NW., Washington, DC 20460,
and (2) OMB by mail to: Office of Information and Regulatory Affairs,
Office of Management and Budget (OMB), Attention: Desk Officer for EPA,
725 17th Street, NW., Washington, DC 20503.

FOR FURTHER INFORMATION CONTACT: Kenon Smith, Clean Air Markets
Division, Office of Air and Radiation, (6204J), Environmental
Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460;
telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>; e-mail
address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: EPA has submitted the following ICR to OBM
for review and approval according to the procedures prescribed in 5 CFR
1320.12. On January 5, 2006 (71 FR 597), EPA sought comments on this
ICR pursuant to 5 CFR 1320.8(d). EPA received 1 comment during the
comment period, which is addressed in the ICR. Any additional comments
on this ICR should be submitted to EPA and OMB within 30 days of this
notice.
    EPA has established a public docket for this ICR under Docket ID
No. EPA-OAR-2005-0509, which is available for online viewing at
http://www.regulations.gov, or in person viewing at the Air and Radiation

Docket and Information Center in the EPA Docket Center (EPA/DC), EPA
West, Room B102, 1301 Constitution Avenue, NW., Washington, DC. The
EPA/DC Public Reading Room is open from 8 a.m. to 4:30 p.m., Monday
through Friday, excluding legal holidays. The telephone number for the
Reading Room is<PHONE_NUMBER>, and the telephone number for the Air and
Radiation Docket and Information Center is<PHONE_NUMBER>.
    Use EPA's electronic docket and comment system at
http://www.regulations.gov, to submit or view public comments, access the

index

listing of the contents of the docket, and to access those documents in
the docket that are available electronically. Once in the system,
select ``docket search,'' then key in the docket ID number identified
above. Please note that EPA's policy is that public comment, whether
submitted electronically or in paper, will be made available for public
viewing at http://www.regulations.gov as EPA receives them and without change,

unless the comment contains copyrighted material, Confidential Business
Information (CBI), or other information whose public disclosure is
restricted by statute. For further information about the electronic
docket, go to http://www.regulations.gov.

    Title: Acid Rain Program.
    ICR numbers: EPA ICR No. 1633.14, OMB Control No. 2060-0258.
    ICR status: This ICR is currently scheduled to expire on June 30,
2006. Under OMB regulations, the Agency may continue to conduct or
sponsor the collection of information while this submission is pending
at OMB. An Agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information, unless it displays
a current valid OMB control number. The OMB control numbers for EPA's
regulations in title 40 of the CFR, after appearing in the Federal
Register when approved, are listed in 40 CFR part 9, are displayed
either by publication in the Federal Register or by other appropriate
means, such as on the related collection instrument or form, if
applicable. The display of OMB control numbers in certain EPA
regulations is consolidated in 40 CFR part 9.
    Abstract: The Acid Rain Program was established under Title IV of
the 1990 Clean Air Act Amendments. The program calls for major
reductions of the pollutants that cause acid rain while establishing a
new approach to environmental management. This information collection
is necessary to implement the Acid Rain Program. It includes burden
hours associated with developing and modifying permits, transferring
allowances, obtaining allowances from the conservation and renewable
energy reserve, monitoring emissions, participating in the annual
auctions, completing annual compliance certifications, participating in
the Opt-in program, and complying with NOX permitting
requirements. Most of this information collection is mandatory under 40
CFR parts 72-78. Some parts of it are voluntary or to obtain a benefit,
such as participation in the annual auctions under 40 CFR part 73,
subpart E.
    Burden Statement: The annual public reporting and recordkeeping
burden for this collection of information is estimated to average 110
hours per response. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, or
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; develop, acquire,
install, and utilize technology and systems for the purposes of
collecting, validating, and verifying information, processing and
maintaining information, and disclosing and providing information;
adjust the existing ways to comply with any previously applicable
instructions and requirements which have subsequently changed; train
personnel to be able to respond to a collection of information; search
data sources; complete and review the collection of information; and
transmit or otherwise disclose the information.
    Respondents/Affected Entities: Electric Utilities, Industrial
Sources, and other persons.
    Estimated Number of Respondents: 1,700.
    Frequency of Response: On occasion, quarterly, and annually.
    Estimated Total Annual Hour Burden: 1,971,276.
    Estimated Total Annual Cost: $262,369,989, which includes
$71,307,000 annualized capital/startup costs, $70,951,000 annual O&M
costs, and $120,111,989 annual labor costs.
    Changes in the Estimates: There is an increase of 370,469 hours in
the total estimated burden currently identified in the OMB Inventory of
Approved ICR Burdens. This increase is due to adjustments (379,044
hours), with changes in program requirements decreasing the burden
(8,575 hours).

    Dated: April 27, 2006.
Oscar Morales,
Director, Collection Strategies Division.
[FR Doc. 06-4352 Filed 5-9-06; 8:45am]

BILLING CODE 6560-50-M


[Federal Register Volume 87, Number 248 (Wednesday, December 28, 2022)]
[Notices]
[Pages 79884-79885]
[FR Doc No: 2022-28248]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: CP23-27-000.
    Applicants: Southern Natural Gas Company, L.L.C.
    Description: Southern Natural Gas Company, L.L.C. submits
Abbreviated Application for Abandonment of the Transportation Agreement
with Texaco, Inc.
    Filed Date: 12/19/22.
    Accession Number: 20221219-5246.
    Comment Date: 5 p.m. ET 1/9/23.

    Docket Numbers: RP22-1031-000.
    Applicants: Transwestern Pipeline Company, LLC.
    Description: Motion Filing: Motion Tariff Records into Effect RP22-
1031-000 to be effective 1/1/2023.
    Filed Date: 12/20/22.
    Accession Number: 20221220-5204.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-296-000.
    Applicants: Carolina Gas Transmission, LLC.
    Description: Compliance filing: CGT--2022 Interruptible Revenue
Sharing Report to be effective N/A.
    Filed Date: 12/20/22.
    Accession Number: 20221220-5037.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-297-000.
    Applicants: Rockies Express Pipeline LLC.
    Description: Sec.  4(d) Rate Filing: REX 2022-12-20 Negotiated Rate
Agreement Amendment to be effective 12/21/2022.
    Filed Date: 12/20/22.
    Accession Number: 20221220-5196.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-298-000.
    Applicants: Great Basin Gas Transmission Company.
    Description: Sec.  4(d) Rate Filing: New Baseline Tariff--First
Revised Version No. 1 to be effective 1/23/2023.
    Filed Date: 12/21/22.
    Accession Number: 20221221-5000.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-299-000.
    Applicants: NGO Transmission, Inc.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate Filing to be
effective 1/1/2023.
    Filed Date: 12/21/22.
    Accession Number: 20221221-5005.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-300-000.
    Applicants: Midcontinent Express Pipeline LLC.
    Description: Sec.  4(d) Rate Filing: Clean Up Filing Dec 2022 to be
effective 2/1/2023.
    Filed Date: 12/21/22.
    Accession Number: 20221221-5007.
    Comment Date: 5 p.m. ET 1/2/23.

    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.

Filings in Existing Proceedings

    Docket Numbers: RP22-1031-002.
    Applicants: Transwestern Pipeline Company, LLC.
    Description: Compliance filing: File and Motion Revised and
Cancelled Tariff Records RP22-1031-000 to be effective 1/1/2023.
    Filed Date: 12/20/22.
    Accession Number: 20221220-5207.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-166-000.
    Applicants: Gulf Run Transmission, LLC.
    Description: Report Filing: Notification CP20-68-000, et al. Actual
In-Service Date 12/16/2022 to be effective N/A.
    Filed Date: 12/19/22.

    Accession Number: 20221219-5174.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-191-000.
    Applicants: Enable Gas Transmission, LLC.
    Description: Report Filing: Notification CP20-68-000, et al. Actual
In-Service Date 12/16/2022 to be effective N/A.
    Filed Date: 12/19/22.
    Accession Number: 20221219-5179.
    Comment Date: 5 p.m. ET 1/2/23.

    Docket Numbers: RP23-191-001.
    Applicants: Enable Gas Transmission, LLC.
    Description: Compliance filing: Supplemental Actual In-Service Date
for CP20-68, et al 12-16-22 to be effective 12/16/2022.
    Filed Date: 12/20/22.
    Accession Number: 20221220-5105.
    Comment Date: 5 p.m. ET 1/2/23.

    Any person desiring to protest in any the above proceedings must
file in accordance with Rule 211 of the Commission's Regulations (18
CFR 385.211) on or before 5:00 p.m. Eastern time on the specified
comment date.
    The filings are accessible in the Commission's eLibrary system
(https://elibrary.ferc.gov/idmws/search/fercgensearch.asp) by querying
the docket number.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: December 21, 2022.
Kimberly D. Bose,
Secretary.
[FR Doc. 2022-28248 Filed 12-27-22; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 218 (Tuesday, November 12, 2019)]
[Proposed Rules]
[Pages 60966-60968]
[FR Doc No: 2019-24511]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1141

[Docket No. FDA-2019-N-3065]
RIN 0910-AI39

Tobacco Products; Required Warnings for Cigarette Packages and
Advertisements; Additional Materials; Reopening of the Comment Period

AGENCY: Food and Drug Administration, HHS.

ACTION: Proposed rule; additional materials; reopening of the comment
period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or the Agency) is
reopening the comment period for the proposed rule that appeared in the
Federal Register of August 16, 2019. The Agency is providing additional
information in the docket and reopening the public comment period for
15 days to afford the public an opportunity to comment on this
additional information.

DATES: FDA is reopening the comment period on the proposed rule
published August 16, 2019 (84 FR 42754). Submit either electronic or
written comments by November 27, 2019. Please note that late, untimely
filed comments will not be considered. Electronic comments must be
submitted on or before November 27, 2019. The https://www.regulations.gov electronic filing system will accept comments until

11:59 p.m. Eastern Time at the end of November 27, 2019.

ADDRESSES: You may submit comments as follows. Comments received by
mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are postmarked or the delivery service
acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2019-N-3065 for ``Tobacco Products; Required Warnings for Cigarette
Packages and Advertisements.'' Received comments, those filed in a
timely manner (see ADDRESSES), will be placed in the docket and, except
for those submitted as ``Confidential Submissions,'' publicly viewable
at https://www.regulations.gov or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Courtney Smith, Center for Tobacco
Products, Food and Drug Administration, Document Control Center, 10903
New Hampshire Ave., Bldg. 71, Rm. G335, Silver Spring, MD 20993-0002,
email<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In the Federal Register of August 16, 2019
(84 FR 42754), FDA published a proposed rule that will, once finalized,
implement a provision of the Family Smoking Prevention and Tobacco
Control Act (Tobacco Control Act) that requires FDA to issue
regulations requiring color graphics depicting the negative health
consequences of smoking to accompany new textual warning statements.
The Tobacco Control Act amends the Federal Cigarette Labeling and
Advertising Act of 1965 to require each cigarette package and
advertisement to bear one of the new required warnings. This proposed
rule, once finalized, will specify the color graphics that must
accompany the new textual warning statements. The proposed new textual
warnings include some that are specified in the Tobacco Control Act and
some new textual warning statements that FDA is proposing to promote
greater public understanding of the negative health consequences of
cigarette smoking. FDA's proposed cigarette warning rule was issued
pursuant to a court-ordered schedule (see Am. Acad. Pediatrics v. FDA,
No. 16-cv-11985, 2019 U.S. Dist. LEXIS 34946 (D. Mass. Mar. 5, 2019)),
which, among other things, requires FDA to submit the proposed rule for
publication by August 15, 2019, and to submit the final rule by March
15, 2020.
    As described in FDA's proposed rule, in developing the new
cigarette health warnings, FDA undertook a science-based, iterative
research process. The proposed rule was informed by two quantitative
consumer research studies, ``Experimental Study on Warning Statements
for Cigarette Graphic Health Warnings'' (Office of Management and
Budget (OMB) control number 0910-0848) and ``Experimental Study of
Cigarette Warnings'' (OMB control number 0910-0866), that assessed the
extent to which FDA's proposed warnings increase understanding of the
negative health consequences of cigarette smoking. As part of
developing and informing its research, FDA conducted various
qualitative focus groups and interviews (``qualitative studies'') to
test and refine image concepts and obtain feedback on which textual
statements should be selected for further study. Qualitative studies
are based on small samples, have exploratory aims and objectives,
should not be viewed as nationally representative, and do not yield
data that can be generalized. FDA did not originally include the
qualitative study reports in the docket as FDA did not rely on these
studies as part of the rulemaking. However, because the qualitative
studies were used to inform further research, namely, the quantitative
consumer research studies, FDA is making these additional materials
available as well.
    FDA is placing additional materials in the docket and reopening the
comment period for the proposed rule for 15 days to allow comment on
the additional materials. The Agency believes that a 15-day reopening
allows adequate time

for interested persons to submit comments on this additional
information without significantly delaying rulemaking.
    FDA is adding the following materials to the docket for the
proposed rule:

 ``Qualitative Study on Cigarettes and Smoking: Knowledge,
Beliefs, and Misperceptions'' (July 2015) (OMB control number 0910-
0674, ``Qualitative Study on Cigarettes and Smoking: Knowledge,
Beliefs, and Misperceptions'')
 ``Memorandum of Findings from Cognitive Testing of Spanish
Warning Labels'' (March 2016)
 ``FDA Graphic Health Warning Image Concept Testing'' (June
2016) (OMB control number 0910-0796, ``Qualitative Study of Perceptions
and Knowledge of Visually Depicted Health Conditions'')
 ``Qualitative Study on Consumer Perceptions of Cigarettes
Health Warning Images'' (April 2018) (OMB control number 0910-0796,
``Qualitative Study on Consumer Perceptions of Cigarettes Health
Warning Images'')

    Dated: November 5, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-24511 Filed 11-8-19; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 50 (Friday, March 14, 2014)]
[Notices]
[Pages 14556-14558]
[FR Doc No: 2014-05593]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-71670; File No. SR-CME-2014-06]

Self-Regulatory Organizations; Chicago Mercantile Exchange, Inc.;
Notice of Filing and Immediate Effectiveness of Proposed Rules Changes
Regarding Implementation of Rules To Address Third Party Swap Execution
Platforms

March 10, 2014.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given that
on February 28, 2014, Chicago Mercantile Exchange Inc. (``CME'') filed
with the Securities and Exchange Commission (``Commission'') the
proposed rule change described in Items I, II and III below, which
Items have been prepared primarily by CME. CME filed the proposal
pursuant to Section 19(b)(3)(A)(iii) of the Act \3\ and Rule 19b-
4(f)(4)(ii) \4\ thereunder so that the proposal was effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \4\ 17 CFR 240.19b-4(f)(4)(ii).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    CME is filing proposed rules changes that address issues relating
to third party swap execution platforms. The proposed rules generally
clarify the time at which the rules of the CME Clearing House
(``Clearing House'') apply, confirm the authority of the Clearing House
to conduct risk management in conformance with its obligations under
applicable regulations, and ensure that the Clearing House has
sufficient flexibility to perform default management as required by
applicable regulations. In addition, the proposed rules ensure that
voids and price adjustments cannot occur after clearing without
Clearing House consent, stipulate that Execution Platforms connected to
the Clearing House comply with regulatory obligations, and require
position transfers to comply with the Clearing House rules. Further,
the proposed rule clarifies that it does not apply to security-based
swaps. The proposed rules are limited to CME's business as a
derivatives clearing organization clearing swaps under the jurisdiction
of the Commodity Futures Trading Commission (``CFTC'').

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, CME included statements
concerning the purpose and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. CME has prepared summaries, set forth in sections A, B,
and C below, of the most significant aspects of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    CME is registered as a derivatives clearing organization with the
Commodity Futures Trading Commission and currently offers clearing
services for many different futures and swaps products. The purpose of
these proposed rule changes is to address issues relating to third
party swap execution platforms. Although these changes will be
effective on filing, CME plans to operationalize the proposed changes
on February 28, 2014.
    Proposed Rule 815 is designed to address the risks posed to the
Clearing House by third party execution platforms for swaps. The
proposed rules: Clarify the time at which the rules of the Clearing
House apply; confirm the authority of the Clearing House to conduct
risk management in conformance with its obligations under CFTC
Regulation 39.13; and ensure that the Clearing House has sufficient
flexibility to perform default management as required under CFTC
Regulations 39.16 and 39.27(b)(4). Proposed Rule 815 also explains that
all third party execution platforms (``Execution Platforms'') that
submit, or have submitted on their behalf, swap trades for clearing to
the Clearing House, are bound by the Clearing House Rules. CME notes
that the Clearing House also separately negotiated provisions in its
commercial agreements with third party execution platforms for swaps
which stipulate that the Clearing House rules apply once a trade has
been submitted for clearing. In addition, the Execution Platforms all
contractually agreed to be bound by the Clearing House rules applicable
to the clearing services provided to them by the Clearing House.
    Proposed Rule 815 specifically confirms that the Clearing House
rules apply once a trade has been submitted for clearing and that the
Clearing House has the sole authority, where circumstances permit, to:
Accept or reject trades, block or cancel trades, block or terminate
connections with Execution Platforms, determine whether it will accept
trade transaction counterparty risk and determine whether contracts are
economically equivalent. In addition, the proposed rules ensure that
voids and price adjustments cannot occur after clearing without
Clearing House consent, stipulate that Execution Platforms connected to
the Clearing House comply with regulatory obligations, and require
position transfers to comply with the Clearing House rules. The
proposed rules are intended to avoid the possibility of unacceptable
ambiguities regarding the clearing and risk management of swap
positions and prevent the actions of third parties from limiting or
interfering with the ability of the Clearing House to perform prudent
risk management and comply with its regulatory obligations. The
proposed

rule does not apply to security-based swaps.
    CFTC Regulations require DCOs like the Clearing House to implement
an enforceable legal framework to address the default of a clearing
member, including but not limited to, the unimpeded ability to
liquidate collateral and close out or transfer positions in a timely
manner. The Clearing House believes that Execution Platforms may
provide the necessary liquidity pools in the future which may assist it
in closing out positions in a timely manner. As such, the Clearing
House determined that it was important to implement a binding rule
providing it with the ability to access the swap liquidity available at
Execution Platforms. As noted above, Execution Platforms agreed to be
bound by the Clearing House rules in their commercial arrangements with
the Clearing House which, in conjunction with these rules, enhances the
legal framework under which the Clearing House manages default risks.
    The changes that are described in this filing are limited to CME's
business as a derivatives clearing organization clearing products under
the exclusive jurisdiction of the Commodity Futures Trading Commission
(``CFTC'') and do not materially impact CME's security-based swap
clearing business in any way. CME notes that it has already submitted
the proposed rule changes that are the subject of this filing to its
primary regulator, the CFTC, in CME Submission 14-060.
    CME believes the proposed rule changes are consistent with the
requirements of the Exchange Act including Section 17A of the Exchange
Act.\5\ The proposed rule changes are generally designed to: Address
risks posed by third party execution platforms for swaps by clarifying
the time at which the rules of the Clearing House apply; confirm the
authority of the Clearing House to conduct risk management in
conformance with its regulatory obligations; and ensure that the
Clearing House has sufficient flexibility to perform default
management. In addition, the proposed rules ensure that voids and price
adjustments cannot occur after clearing without Clearing House consent,
stipulate that Execution Platforms connected to the Clearing House
comply with regulatory obligations, and require position transfers to
comply with the Clearing House rules. Further, the proposed rule
clarifies that it does not apply to security-based swaps. These
purposes promote the prompt and accurate clearance and settlement of
securities transactions and, to the extent applicable, derivatives
agreements, contracts, and transactions, to assure the safeguarding of
securities and funds which are in the custody or control of the
clearing agency or for which it is responsible, and, in general, to
protect investors and the public interest consistent with Section
17A(b)(3)(F) of the Exchange Act.\6\
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78q-1.
    \6\ 15 U.S.C. 78q-1(b)(3)(F).
---------------------------------------------------------------------------

    Furthermore, the proposed changes are limited in their effect to
swaps products offered under CME's authority to act as a derivatives
clearing organization. These products are under the exclusive
jurisdiction of the CFTC. As such, the proposed CME changes are limited
to CME's activities as a derivatives clearing organization clearing
swaps that are not security-based swaps; CME notes that the policies of
the CFTC with respect to administering the Commodity Exchange Act are
comparable to a number of the policies underlying the Exchange Act,
such as promoting market transparency for over-the-counter derivatives
markets, promoting the prompt and accurate clearance of transactions
and protecting investors and the public interest.
    Because the proposed changes are limited in their effect to swaps
products offered under CME's authority to act as a derivatives clearing
organization, the proposed changes are properly classified as effecting
a change in an existing service of CME that:
    (a) Primarily affects the clearing operations of CME with respect
to products that are not securities, including futures that are not
security futures, and swaps that are not security-based swaps or mixed
swaps; and
    (b) does not significantly affect any securities clearing
operations of CME or any rights or obligations of CME with respect to
securities clearing or persons using such securities-clearing service.

As such, the changes are therefore consistent with the requirements of
Section 17A of the Exchange Act \7\ and are properly filed under
Section 19(b)(3)(A) \8\ and Rule 19b-4(f)(4)(ii) \9\ thereunder.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78q-1.
    \8\ 15 U.S.C. 78s(b)(3)(A).
    \9\ 17 CFR 240.19b-4(f)(4)(ii).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    CME does not believe that the proposed rule change will have any
impact, or impose any burden, on competition. The proposed rule changes
address potential risks posed to the Clearing House by third party
execution platforms. The proposed rules clarify the time at which the
rules of the Clearing House apply; confirm the authority of the
Clearing House to conduct risk management in conformance with its
regulatory obligations; and ensure that the Clearing House has
sufficient flexibility to perform default management. In addition, the
proposed rules ensure that voids and price adjustments cannot occur
after clearing without Clearing House consent, stipulate that Execution
Platforms connected to the Clearing House comply with regulatory
obligations, and require position transfers to comply with the Clearing
House rules. Further, the proposed rule clarifies that it does not
apply to security-based swaps. These purposes do not act as a restraint
on competition but rather are prudent measures in line with the
Clearing House's regulatory risk management obligations.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    CME has not solicited, and does not intend to solicit, comments
regarding this proposed rule change. CME has not received any
unsolicited written comments from interested parties.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to Section
19(b)(3)(A) \10\ of the Act and Rule 19b-4(f)(4)(ii) \11\ thereunder.
At any time within 60 days of the filing of the proposed rule change,
the Commission summarily may temporarily suspend such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78s(b)(3)(A).
    \11\ 17 CFR 240.19b-4(f)(4)(ii).
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml ), or

     Send an email to<EMAIL_ADDRESS>Please include File
No. SR-CME-2014-06 on the subject line.

Paper Comments

     Send paper comments in triplicate to Secretary, Securities
and Exchange Commission, 100 F Street NE., Washington, DC 20549-1090.

All submissions should refer to File Number SR-CME-2014-06. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml
). Copies of the submission, all subsequent amendments, all written
statements with respect to the proposed rule change that are filed with
the Commission, and all written communications relating to the proposed
rule change between the Commission and any person, other than those
that may be withheld from the public in accordance with the provisions
of 5 U.S.C. 552, will be available for Web site viewing and printing in
the Commission's Public Reference Room, 100 F Street NE., Washington,
DC 20549, on official business days between the hours or 10:00 a.m. and
3:00 p.m. Copies of such filing also will be available for inspection
and copying at the principal office of CME and on CME's Web site at
http://www.cmegroup.com/market-regulation/rule-filings.html.
    All comments received will be posted without change; the Commission
does not edit personal identifying information from submissions. You
should submit only information that you wish to make available
publicly. All submissions should refer to File Number SR-CME-2014-06
and should be submitted on or before April 4, 2014.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\12\
---------------------------------------------------------------------------

    \12\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2014-05593 Filed 3-13-14; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 79, Number 93 (Wednesday, May 14, 2014)]
[Notices]
[Pages 27685-27686]
[FR Doc No: 2014-11082]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[FMCSA Docket No. FMCSA-2014-0012]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to exempt 50 individuals from its
rule prohibiting persons with insulin-treated diabetes mellitus (ITDM)
from operating commercial motor vehicles (CMVs) in interstate commerce.
The exemptions will enable these individuals to operate CMVs in
interstate commerce.

DATES: The exemptions are effective May 14, 2014. The exemptions expire
on May 16, 2016.

FOR FURTHER INFORMATION CONTACT: Elaine M. Papp, Chief, Medical
Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA, Room
W64-224, Department of Transportation, 1200 New Jersey Avenue SE.,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
Monday through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

Electronic Access

    You may see all the comments online through the Federal Document
Management System (FDMS) at: http://www.regulations.gov.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's Privacy Act Statement for the Federal
Docket Management System (FDMS) published in the Federal Register on
January 17, 2008 (73 FR 3316).

Background

    On February 25, 2013, FMCSA published a notice of receipt of
Federal diabetes exemption applications from 50 individuals and
requested comments from the public (79 FR 10612). The public comment
period closed on March 27, 2014 and two comments were received.
    FMCSA has evaluated the eligibility of the 50 applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).

Diabetes Mellitus and Driving Experience of the Applicants

    The Agency established the current requirement for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
    FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal
Register notice in conjunction with the November 8, 2005 (70 FR 67777),
Federal Register notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
    These 50 applicants have had ITDM over a range of 1 to 36 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (2 or
more) severe hypoglycemic episodes in the past 5 years. In each case,
an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes-related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
    The qualifications and medical condition of each applicant were
stated and discussed in detail in the February 25, 2014, Federal
Register notice and they will not be repeated in this notice.

Discussion of Comments

    FMCSA received two comments in this proceeding. The comments are
discussed below.
    John Navarro is in favor of granting all drivers exemptions.
    Jason Runyon corrected the spelling of his name from ``James'', as
it appeared in FMCSA-2014-0012-0001 (79 FR 10612). The spelling has
been corrected below.

Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption
is likely to achieve an equivalent or greater level of safety than
would be achieved without the exemption. The exemption allows the
applicants to operate CMVs in interstate commerce.
    To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
    Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.

Conditions and Requirements

    The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of

hypoglycemia; (3) that each individual provide a copy of the
ophthalmologist's or optometrist's report to the medical examiner at
the time of the annual medical examination; and (4) that each
individual provide a copy of the annual medical certification to the
employer for retention in the driver's qualification file, or keep a
copy in his/her driver's qualification file if he/she is self-employed.
The driver must also have a copy of the certification when driving, for
presentation to a duly authorized Federal, State, or local enforcement
official.

Conclusion

    Based upon its evaluation of the 50 exemption applications, FMCSA
exempts Franklin D. Bailey (GA), Tony T. Bakkala (WA), RobRoy Barney
(MT), Aaron C. Bogle (OH), Todd L. Brandt (IL), Dean G. Brekhus (ND),
Kenneth L. Brooks, Jr. (NC), Angie M. Carrington (MO), David A. Cavan
(MA), David A. Charles (OH), Philip M. Clardy (MI), James A. David
(IL), Samuel J. Desmond (RI), David A. Doeling (ND), Mark C. Durler
(KS), Nathaniel Edwards, Sr. (TN), John F. Fedorchak, Jr. (PA), Roger
A. Felix (IN), Derek W. Frazier (IA), Harry M. Gallagher (WA), Michael
G. Haugen (WI), Richard E. Hazek (OH), Timothy S. Hinkhouse (NE), Gregg
W. Isherwood (ME), William L. Ivey (WA), Chad D. Johansen (UT), Kevin
Krummenacker (NY), James A. Lagunas (AZ), Douglas R. Lane (NY),
Jonathon W. Luebke (WI), Brion T. Maguire (PA), Christopher P. Martin
(NH), Jacob R. Martin (MO), John C. May (NE), Daryl J. Millard (WA),
Angel F. Morales (CO), Neil J. Morrison (IL), Peter Odo (IL), Slobodan
Pavlovich (WA), Darryl W. Peppers (IN), Bradley S. Pletcher (PA),
Michael G. Pollard (IA), Hank D. Rose, Jr. (NC), Jason M. Runyon (OK),
Michael J. Schroeder (WI), Mary E. Schultz (WI), David H. Sopko (UT),
David G. Stookey (WA), Thomas P. Verdon (PA), and Joshua R. Wiery (OH)
from the ITDM requirement in 49 CFR 391.41(b)(3), subject to the
conditions listed under ``Conditions and Requirements'' above.
    In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if the following occurs: (1) The person fails to comply
with the terms and conditions of the exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the
exemption is still effective at the end of the 2-year period, the
person may apply to FMCSA for a renewal under procedures in effect at
that time.

    Issued on: April 28, 2014.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2014-11082 Filed 5-13-14; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register Volume 81, Number 1 (Monday, January 4, 2016)]
[Notices]
[Page 135]
[FR Doc No: 2015-33028]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

In the Matter of Zhong Wen International Holding Co., Ltd.; Order
of Suspension of Trading

December 29, 2015.
    It appears to the Securities and Exchange Commission
(``Commission'') that there is a lack of current and accurate
information concerning the securities of Zhong Wen International
Holding Co., Ltd. (``ZWIH \1\'') (CIK No. 1494502), a void Delaware
corporation whose principal place of business is listed as Qingzhou,
Shandong, China because it is delinquent in its periodic filings with
the Commission, having not filed any periodic reports since it filed a
Form 10-Q for the period ended September 30, 2012. On February 19,
2015, the Commission's Division of Corporation Finance sent a
delinquency letter to ZWIH at the address shown in its then-most recent
filing in the Commission's EDGAR system requesting compliance with its
periodic filing requirements. To date, ZWIH has failed to cure its
delinquencies. As of December 15, 2015, the common stock of ZWIH was
quoted on OTC Link operated by OTC Markets Group, Inc. (formerly ``Pink
Sheets'') had three market makers and was eligible for the
``piggyback'' exception of Exchange Act Rule 15c2-11(f)(3).
---------------------------------------------------------------------------

    \1\ The short form of the issuer's name is also its ticker
symbol.
---------------------------------------------------------------------------

    The Commission is of the opinion that the public interest and the
protection of investors require a suspension of trading in the
securities of the above-listed company. Therefore, it is ordered,
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that
trading in the securities of the above-listed company is suspended for
the period from 9:30 a.m. EST on December 29, 2015, through 11:59 p.m.
EST on January 12, 2016.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-33028 Filed 12-31-15; 8:45 am]
 BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 225 (Wednesday, November 21, 2012)]
[Notices]
[Page 69819]
[FR Doc No: 2012-28271]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[ Docket No. ER13-354-000]

QC Power Strategies Fund LLC; Supplemental Notice That Initial
Market-Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding,
of QC Power Strategies Fund LLC's application for market-based rate
authority, with an accompanying rate schedule, noting that such
application includes a request for blanket authorization, under 18 CFR
part 34, of future issuances of securities and assumptions of
liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability is December 5, 2012.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding(s) are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: November 15, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-28271 Filed 11-20-12; 8:45 am]
BILLING CODE 6717-01-P